Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1976;47:50-55
© 1976 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILLER, F. C.
Right arrow Articles by HON, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MILLER, F. C.
Right arrow Articles by HON, E. H.

Effects of Ritodrine Hydrochloride on Uterine Activity and the Cardiovascular System in Toxemic Patients

FRANK C. MILLER, MD, LtC, MC, FACOG, DAVID J. NOCHIMSON, MD, FACOG, RICHARD H. PAUL, MD, FACOG and EDWARD H. HON, MD, FACOG

From the Department of Obstetrics and Gynecology, Section of Perinatal Biology of the Los Angeles County-University of Southern California Medical Center

Abstract

The effects of ritodrine hydrochloride were evaluated in 25 toxemic patients in active labor utilizing continuous electronic monitoring of fetal and maternal cardiovascular systems and uterine activity. Fetal scalp blood and free flowing maternal antecubital venous blood was obtained for pH, Po2, Pco2, base deficit and blood glucose determinations prior to and immediately following the study period. The initial ritodrine dose was 50 µg/min for 15 minutes. The dose was increased by 50 µg/min each 15 minutes until there was a clinically apparent reduction in uterine activity. Once this was accomplished, the infusion was maintained for 30 minutes. There was a consistent increase in the maternal heart rate (MHR) and a significant rise in fetal heart rate (FHR) late in the infusion and in the postinfusion period. There was a widening of the maternal pulse pressure mainly due to a reduction in diastolic pressure with little change in the mean blood pressure. Maternal and fetal pH decreased and base deficit increased during the study although the Po2 and Pco2 remained unchanged. Maternal and fetal blood glucose rose significantly following ritodrine infusion.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by the American College of Obstetricians and Gynecologists.